Meiwu Technology Company Limited experienced a dramatic recovery in premarket trading on Tuesday, with shares surging 87.99% to $4.531. This bounce comes after a steep 22.76% decline on Monday, which left the stock closing at $2.410. The Nasdaq-listed company, trading under the ticker WNW, has been the subject of intense market activity following recent corporate developments.
The premarket rally, observed at 7:01 a.m. EDT, stands in stark contrast to Monday's session, where shares opened at $3.150, hit the same high, and later slid to a low of $2.250, according to Webull data. Premarket trading often exhibits heightened volatility due to lower liquidity and fewer orders in the order book, which can amplify price swings. The main Nasdaq trading session runs from 9:30 a.m. to 4:00 p.m. Eastern, and May 19 is not a U.S. market holiday; the next full closure is Memorial Day on May 25.
The broader market showed mixed performance on Monday, with the Nasdaq Composite falling 0.5%, the Dow Jones Industrial Average gaining 0.3%, and the S&P 500 edging down 0.1%. Geopolitical concerns and fluctuating oil prices have contributed to choppy trading conditions, as reported by the Associated Press.
Meiwu's recent financing activities have captured investor attention. In a Form 6-K filed with the SEC, the company disclosed that it raised approximately $15.65 million through a private placement of 25 million ordinary shares at $0.626 per share. This type of transaction, known as a private investment in public equity (PIPE), involves selling newly issued stock to select investors. A key concern for existing shareholders is dilution, as the increased share count reduces each holder's proportional ownership unless the raised capital generates sufficient value.
The company has stated that the funds will be primarily allocated to the development of an AI-driven skincare management platform, along with digital infrastructure, working capital, and other corporate needs. Investors in the PIPE have agreed to a 12-month lock-up period, and Meiwu has also committed to restrictions on certain new share sales and variable-rate deals for one year.
Meiwu's business model has undergone rapid transformation. According to Reuters, the company is a holding company focused on functional skincare, with segments covering skincare, quality food products, and technical services. For 2025, Meiwu reported revenue of $7.08 million and a net loss of $18.59 million. Management views the shift toward skincare as both a product and data challenge. In March, CEO Zhichao Yang noted that AI tools could assist teams in managing complex datasets and streamlining internal workflows, particularly in areas such as formulation records and ingredient research.
The company faces intense competition in the beauty sector, naming Winona, Pechoin, and Chando as key rivals. Meiwu is positioning itself as a platform for functional skincare, targeting specific skin concerns rather than traditional cosmetics. To meet Nasdaq listing requirements, the company executed a 1-for-100 reverse stock split on April 6, which consolidated shares to boost the per-share price without changing the company's overall value. Nasdaq also assigned a new CUSIP number, G9604C131.
However, significant risks remain. In its May filing, Meiwu cautioned that its planned AI skincare platform is still in early stages and may not launch or reach the market. The company highlighted regulatory risks related to healthcare, medical devices, consumer protection, artificial intelligence, data privacy, and cybersecurity. It also noted potential challenges in hiring qualified technical staff.
Tuesday's regular trading session will reveal whether the premarket gains hold. For now, the sharp bounce in this small, heavily restructured stock reflects trader sentiment rather than a fundamental shift in the company's operations.
